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Abstract
Background: Coxiella burnetii is an obligate bacterial pathogen that causes Q fever. Cytomegalovirus (CMV)
commonly exists as a latent infection in healthy people. Co-infection with both pathogens is rare.
Case presentation: We report an immunocompetent 53-year-old male farmer who presented with fulminant
hepatic failure and acute renal failure. Empiric antibiotic treatment with intravenous penicillin G and levofloxacin
were given, but hepatic and renal functions continued to deteriorate. A subsequent test of serum immunoglobulin
M was positive for CMV, and administration of gancyclovir led to gradual recovery. A diagnosis of acute Q fever was
confirmed by indirect immunofluorescence assay (IFA) on paired serum samples to demonstrate a significant rise in
antibody titers. Antibiotic treatment was adjusted accordingly.
Conclusion: CMV co-infection should be considered in patients with acute Q fever when they do not respond to
standard antimicrobial agents.
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Background
Q fever is an emerging zoonosis caused by infection with
Rickettsiae agent, Coxiella burnetii [1]. Q fever is charac-
terized by fever with interstitial pneumonitis. Sixty percent
of infected individuals are asymptomatic, but rare cases
can develop fulminant hepatic failure and even acute renal
failure [2,3]. Cytomegalovirus (CMV) infection is typically
a latent asymptomatic disease in otherwise healthy people.
However, CMV-related hepatitis is common in immuno-
compromised patients, such as transplant recipients and
neonates [4], and can also occur in immunocompetent pa-
tients [5,6]. Herein, we report an immunocompetent man
infected with C. burnetii and CMV who presented with
fulminant hepatic failure and acute renal failure.
Case presentation
A 53-year-old male farmer who bred geese, fowls, dogs,
and cats, and had frequent contact with their carcasses
presented at our institution with intermittent fever for
the previous week in July of 2013. He reported taking anti-
histamines for his urticaria in recent years. His symptoms
included general malaise, icteric sclera, yellowish skin, bi-
lateral plantar skin rash, and a headache in the temporal
and frontal areas. He denied any history of travel, unpro-
tected sex, insect bites, transfusion, or toxin exposure.
On admission, his body temperature was 39.1°C, pulse
rate was 110 beats per minute, and blood pressure was
121/82 mmHg. He was oriented but had mild agitation.
He had icteric sclera but no Kayser-Fleischer ring; his
abdomen was not tender, and he had yellowish skin with
several linear and erythematous lesions over bilateral
plantar areas, but no eschar-like lesions. The results of a
neurologic examination were unremarkable. A hemogram
indicated a leukocyte count of 11,770/μL with 13% mono-
cytes, and a platelet count of 85,000/μL. The prothrombin
time was 19.1 s (reference range: 8-12 s) and the activated
partial thromboplastin time was 36.2 s (reference range:
23.9-35.5 s). Biochemical analysis indicated elevated aspar-
tate aminotransferase (2561 IU/L), alanine aminotransfer-
ase (2263 IU/L), alkaline phosphatase (274 IU/L), gamma
glutamyltransferase (824 IU/L), total bilirubin (7.2 mg/dL),
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direct bilirubin (6.2 mg/dL), urea nitrogen (30 mg/dL),
creatinine (2.6 mg/dL), and C-reactive protein (4.23 mg/
dL). Analysis of arterial blood gas indicated a pH of 7.439
(reference range: 7.38-7.42) and HCO3
- of 19.5 mEq/L (ref-
erence range: 22-28 mEq/L). A chest X-ray was unremark-
able but an abdominal computed tomography indicated
generally decreased liver parenchymal attenuation and
mild ascites, compatible with a diagnosis of hepatitis
(Figure 1).
He was treated empirically with parenteral penicillin G
(3 MU every 8 h) and parenteral levofloxacin (500 mg
every 24 h) under impression of Leptospirosis and gram-
negative bacterial infection. However, his fever persisted
and he became drowsy with asterixis on day 6. At this
time, there were also increases in the total bilirubin
(18.2 mg/dL), direct bilirubin (14.2 mg/dL), and serum
creatinine (5.9 mg/dL). Levofloxacin was discontinued and
parenteral ceftazidine (2 g every 24 h) and vancomycin
(1 g every 72 h) were administered. However, his condition
continued to deteriorate. On day 8, there were generalized
dark-red, painless, non-blanching macules over his trunk
and four limbs and his serum total bilirubin had increased
to 26.5 mg/dL. Penicillin G was replaced by oral doxycyc-
line (100 mg every 12 h). There was no bacteria growth in
blood cultures, and the serum anti-HAV IgM, HBsAg,
anti-HCV Ab, anti-EB-VCA IgM, anti-HIV antibody, anti-
HSV IgM and IgG were negative. Ceruloplasmin, anti-
smooth muscle antibody, and anti-nuclear Ab were within
the normal ranges. The serum collected for Q fever and
Leptospira on day 2 was negative. Polymerase chain reac-
tion (PCR) for C. burnetii also showed negative. On day
10, the serum anti-CMV IgM test was positive and he was
given parenteral gancyclovir, after which his conscious-
ness, liver, and renal function improved.
On day 12, the phase II IgG for Q fever by immuno-
fluorescent assay (IFA) was 1:320, and phase II IgM for
Q fever was negative (performed at Taiwan Centers for
Disease Control). According to the diagnostic criteria [7],
the patient’s course was compatible with acute Q fever.
Microscopic agglutination tests using serum antibodies
against Leptospira santarosai serovar shermani, L. borgpe-
tersenii serovar poi, and L. tarassovi (performed at Taiwan
Centers for Disease Control) were negative. Parenteral
levofloxacin (500 mg every 24 h) was reinitiated on day 21.
On day 27, there were decreases in the serum total
bilirubin (9.9 mg/dL) and creatinine (1.65 mg/dL) and
the patient was discharged. After completion of a 24-week
course of oral levofloxacin (500 mg every 24 h), there was
normalization of the serum total bilirubin (0.8 mg/dL) and
serum creatinine (1.04 mg/dL). A follow-up abdominal CT
at 4 months indicated normal liver parenchymal attenu-
ation without ascites. During the subsequent follow-up, he
had not recurrent episodes or other discomfort. Figure 2
summarizes the clinical, laboratory and drug treatments.
Conclusion
About 60% of patients with Q fever are asymptomatic,
but patients with acute Q fever develop febrile episodes
that are accompanied by atypical pneumonia (47% of
cases), hepatitis (5% of cases), occasionally clinical hep-
atomegaly, and rarely jaundice [7]. A case report identi-
fied a patient with Q fever and granulomatous hepatitis
[8]. In Taiwan, hepatitis was reported in 55% of patients
with Q fever, and fulminant hepatic failure was rare [9].
Glomerulonephritis was recognized in chronic Q fever
due to complications of endocarditis [10]. However, acute
renal failure due to Q fever is rare [11]. In the present
case, we identified a patient with Q-fever and CMV infec-
tion who presented with fulminant hepatic failure and
acute renal failure.
The criteria for confirmation of acute Q fever is a titer
of phase II IgM > = 80 or a fourfold increase of phase II
IgG titers [7]. In our current case, the diagnosis of acute
Q fever is based on the titer change of phase II IgG
(from negative to 1:320 by IFA). However, the PCR of C.
burnetii on 2nd admission day and phase II IgM titer on
12th admission day are both negative. A report from
Taiwan Centers for Disease Control (TCDC) in 2011
used PCR and IgM IFA to check the serum of patients
who diagnosed as acute Q fever by serology [12]. They
found 29% patients with phase II IgM titer > = 80; 60%
patients with positive PCR assay, and 78% patients with
one of PCR and IgM titer > = 80. In other word, 71% pa-
tients are phase II IgM titer < 80; 40% patients have
negative PCR; 22% patients have both negative. In our
current case, it belongs to both negative. However, the
use of PCR assay can actually facilitate the early diagno-
sis of acute Q fever.
Figure 1 Non-contrast computed tomography of the abdomen
on admission showed generally decreased liver parenchymal
attenuation and mild ascites (arrow), compatible with
acute hepatitis.
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Taiwan has many carriers of chronic hepatitis B and C
[13], and the clinical manifestation of hepatitis due to
acute Q fever is similar to those of patients with viral
hepatitis. In addition, there is apparently no difference in
replication of the hepatitis virus after acute Q fever
hepatitis [14]. Thus, the presence of chronic hepatitis B
and C infection seems unrelated to the development of
Q fever symptoms.
CMV often co-infects patients with human immuno-
deficiency virus [15], pneumocystis jeroveci [16], herpes
simplex virus [17], clostridium difficile [18], Epstein- Barr
virus [19], and those with acquired immunodeficiency syn-
drome or who use immunosuppressants. In the present
case, fulminant hepatic failure and acute renal failure oc-
curred simultaneously. These symptoms are suggestive of
Weil’s disease, caused by Leptospira [20,21], which we
were able to exclude. We later confirmed a diagnosis of Q
fever. The causative microbe (C. burnetti) should be sensi-
tive to levofloxacin, but the patient did not respond to the
initial therapy of penicillin and levofloxacin, and his jaun-
dice only subsided after use of gancyclovir. This indicates
an important role of CMV infection in this case. However,
CMV infection is latent in healthy people, and severe
hepatitis only occurs in immune-compromised patients
[4]. Previous reports indicated that CMV infection occurs
in 0 to 36% of critically ill patients, mostly at 4 to 12 days
after ICU admission [22]. Most cases with CMV infection
present with pneumonia, and a small number present with
liver involvement [5,6]. In addition, cases with CMV-
related hepatitis often present with mild elevations of liver
enzymes and bilirubin, and only rarely with fulminant
hepatic failure [4]. In the present case, we could not deter-
mine if acute hepatic failure due to Q fever reactivated the
latent CMV, or if a reactivated CMV infection precipitated
acute hepatic failure and Q fever.
In conclusion, co-infection with CMV and C. burnetti
can cause acute hepatic and renal failure, with symp-
toms that mimic Weil’s disease (Leptospirosis). CMV
co-infection should be considered in patients who present
with Q fever when there is no response to the standard
antimicrobial agents used against C. burnetti.
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